V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002303 | 240002303 | null | null | null | null | 2015-12-22 | null | null | null | SUNITINIB | 100169218 |
| 240002304 | 240002304 | null | null | null | null | 2017-05-08 | Methotrexate intrathecal | null | null | CHOP R | 101591510 |
| 240002311 | 240002311 | null | null | null | null | 2019-01-02 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101215538 |
| 240002315 | 240002315 | null | null | null | null | 2016-12-27 | AXITINIB | null | null | TRIPLE INTRATHECAL | 100052435 |
| 240002317 | 240002317 | 1.68 | 16.6 | Curative (C) | null | 2017-02-01 | Azacitidine | 02 | N | NOT MATCHED | 100926382 |
| 240002319 | 240002319 | 1.55 | 92.65 | Curative (C) | null | 2020-03-17 | null | N | N | NOT MATCHED | 101744469 |
| 240002322 | 240002322 | 1.88 | null | Curative (C) | null | 2016-11-15 | Chlorambucil | Y | Y | TRIAL UNSPECIFIED | 100350481 |
| 240002323 | 240002323 | null | null | null | null | 2018-12-08 | CHOP R | null | null | AML18 TRIAL | 101286007 |
| 240002326 | 240002326 | 1.66 | 117 | Curative (C) | 2017-02-03 | 2017-02-04 | AML MyeChild 01 IT Cyt | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101104111 |
| 240002339 | 240002339 | null | null | null | null | 2016-05-23 | null | null | null | AML18 TRIAL | 100856369 |
| 240002343 | 240002343 | 0 | 98 | Curative (C) | null | 2019-04-22 | null | 02 | N | CHOP R | 101426908 |
| 240002347 | 240002347 | 1.64 | 114 | Palliative (P) | 2019-07-29 | 2019-07-29 | Trial Unspecified | 02 | N | TRIPLE INTRATHECAL | 100189867 |
| 240002350 | 240002350 | null | null | null | null | 2019-09-05 | null | null | null | TRIAL UNSPECIFIED | 101108568 |
| 240002351 | 240002351 | null | null | null | null | 2017-06-05 | null | null | null | CHOP R | 100578083 |
| 240002356 | 240002356 | 0 | 81.3 | Adjuvant (A) | 2018-07-10 | 2018-07-10 | CHOP R | 1 | N | CYTARABINE + DAUNORUBICIN | 100222381 |
| 240002357 | 240002357 | 1.67 | 69 | Curative (C) | null | 2021-01-14 | CHOP - 21 days | 2 | N | AML19 TRIAL | 101453016 |
| 240002358 | 240002358 | 1.61 | null | Curative (C) | 2017-02-13 | 2017-02-14 | Trial Unspecified | 02 | N | FCR | 100700119 |
| 240002360 | 240002360 | 1.58 | 85 | Curative (C) | 2019-07-19 | 2019-07-21 | null | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101498904 |
| 240002364 | 240002364 | null | null | null | null | 2017-09-07 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101268927 |
| 240002389 | 240002389 | null | null | null | null | 2019-08-28 | Hydroxycarbamide | null | null | CYTARABINE | 100804433 |
| 240002393 | 240002393 | 1.83 | 65 | Palliative (P) | null | 2019-05-29 | RUXOLITINIB | 02 | Y | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100445404 |
| 240002394 | 240002394 | null | null | null | null | 2019-01-11 | DA-EPOCH-R | null | null | CHOP R | 100080664 |
| 240002400 | 240002400 | 0 | 89.6 | Curative (C) | null | 2016-05-09 | null | null | N | CHOP R | 101600440 |
| 240002404 | 240002404 | null | null | null | null | 2016-11-29 | CHOP R | null | null | CLADRIBINE | 101815117 |
| 240002406 | 240002406 | null | null | null | null | 2018-06-06 | null | null | null | AML19 TRIAL | 101715564 |
| 240002408 | 240002408 | 1.68 | 0 | Adjuvant (A) | 2019-05-01 | 2019-05-06 | AML 19 TRIAL | 02 | N | CHOP R | 101831406 |
| 240002418 | 240002418 | 1.77 | 78.3 | Curative (C) | 2020-12-10 | 2020-12-10 | null | 02 | N | AML18 TRIAL | 100515222 |
| 240002421 | 240002421 | 1.5 | 50.9 | 03 | null | 2018-11-03 | BENDAMUSTINE + RITUXIMAB | N | N | HYDROXYCARBAMIDE | 100148329 |
| 240002425 | 240002425 | 1.82 | 111.8 | Neo-adjuvant (N) | null | 2016-12-14 | GEMTUZUMAB OZOGAMICIN | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101837124 |
| 240002432 | 240002432 | null | null | null | null | 2016-06-17 | null | null | null | HYDROXYCARBAMIDE | 100120201 |
| 240002433 | 240002433 | 1.58 | 75 | 03 | null | 2016-04-17 | null | 02 | N | IBRUTINIB | 101072073 |
| 240002440 | 240002440 | null | null | null | null | 2022-02-22 | DA 3 + 10 | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 100171381 |
| 240002444 | 240002444 | 1.57 | 83.2 | 03 | 2017-11-08 | 2017-11-09 | AML 19 TRIAL | 02 | N | BORTEZOMIB + THALIDOMIDE | 100239144 |
| 240002445 | 240002445 | 1.7 | 80 | Curative (C) | null | 2017-01-17 | null | 01 | N | AML19 TRIAL | 100221166 |
| 240002453 | 240002453 | 1.72 | 46 | Curative (C) | null | 2016-10-27 | null | N | N | TRIPLE INTRATHECAL | 100564439 |
| 240002467 | 240002467 | 1.67 | 63.1 | null | null | 2017-11-28 | FLAG | N | N | CHOP R | 101403697 |
| 240002468 | 240002468 | 1.66 | 86.1 | Disease modification (D) | 2017-07-09 | 2017-07-09 | ATG + Busulfan + Fludarabine | 02 | N | HYDROXYCARBAMIDE | 101132559 |
| 240002479 | 240002479 | null | null | null | null | 2016-08-14 | GEMTUZUMAB OZOGAMICIN | null | null | NOT MATCHED | 100574708 |
| 240002503 | 240002503 | null | 98.4 | Curative (C) | null | 2017-03-23 | Cytarabine Low Dose | 02 | N | HYDROXYCARBAMIDE | 101580316 |
| 240002504 | 240002504 | null | null | null | null | 2019-09-27 | null | null | null | AML19 TRIAL | 101763300 |
| 240002505 | 240002505 | 1.71 | 30 | Curative (C) | 2018-07-29 | 2018-07-31 | UKALL14- Maintenance + Imatinib | null | N | AML18 TRIAL | 100891038 |
| 240002510 | 240002510 | null | null | null | null | 2019-04-24 | DOXORUBICIN | null | null | CYTARABINE + DAUNORUBICIN | 101776866 |
| 240002522 | 240002522 | 1.62 | 71.1 | Curative (C) | 2017-07-01 | 2017-07-01 | null | 02 | N | DA | 100113108 |
| 240002530 | 240002530 | null | null | null | null | 2016-02-27 | Bortezomib +/- Dexamethasone | null | null | TRIAL UNSPECIFIED | 101456655 |
| 240002532 | 240002532 | 1.68 | 55 | Curative (C) | 2019-01-06 | 2019-01-12 | null | N | N | DA | 100335586 |
| 240002534 | 240002534 | 1.8 | 57.1 | Curative (C) | null | 2016-10-22 | AML 19 TRIAL | 02 | Y | ALEMTUZUMAB | 100774168 |
| 240002535 | 240002535 | 1.73 | 72 | Curative (C) | null | 2017-06-11 | null | Y | N | CYTARABINE + DAUNORUBICIN | 101139453 |
| 240002536 | 240002536 | null | null | null | null | 2016-06-18 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | null | null | DA | 100869746 |
| 240002540 | 240002540 | 0 | 104 | Curative (C) | null | 2018-04-01 | AML 18 TRIAL | N | N | DA | 101825739 |
| 240002543 | 240002543 | 0.96 | 65.6 | Curative (C) | 2018-03-18 | 2018-03-18 | null | 02 | N | AML19 TRIAL | 100371794 |